Clinical Trial Update: PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing PEGPH20 plus nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine in untreated stage IV pancreatic cancer; tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• PEGPH20 (pegylated hyaluronidase)

Snippet

Sponsor: Halozyme Therapeutics | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-07-20